| Net Cash Provided by (Used in) Operating Activities |
$19,702 |
USD |
89% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$19,430 |
USD |
-89% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
37,997,373 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,609 |
USD |
7.9% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,555,906 |
USD |
32% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$2,555,906 |
USD |
32% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
5,850,000 |
shares |
|
Q1 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
|
Q1 2025 |
Q3 2025 |
| Additional Paid in Capital |
$9,660,699 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
5,850,000 |
shares |
|
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$12,716 |
USD |
337% |
Q3 2025 |
Q1 2026 |